ZMAT4 inhibitors belong to a specific class of chemical compounds designed to target and modulate the activity of the ZMAT4 protein within biological systems. ZMAT4, short for Zinc Finger Matrin-type 4, is a protein that plays a critical role in various cellular processes, particularly in the regulation of gene expression and RNA metabolism. These inhibitors are designed to interfere with the normal functioning of ZMAT4, either by binding to the protein directly or by disrupting its interactions with other molecules.
At the molecular level, ZMAT4 inhibitors are typically small organic molecules characterized by their ability to interact with specific regions of the ZMAT4 protein. This interaction can occur through various mechanisms, such as competitive binding to the protein's active site or allosteric modulation, which alters the protein's three-dimensional structure and consequently affects its activity. By inhibiting ZMAT4, these compounds can potentially influence gene expression patterns, RNA processing, and other cellular functions that rely on the proper functioning of ZMAT4. Researchers are actively exploring the development of ZMAT4 inhibitors as valuable tools for studying the biological roles of ZMAT4 and for investigating the consequences of its dysregulation in various diseases.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Inhibits CDK4/6, indirectly affecting ZMAT4 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor, altering ZMAT4 regulation. | ||||||
Polo-like Kinase Inhibitor III | 660868-91-7 | sc-203202 | 500 µg | $109.00 | 1 | |
Suppresses Cyclin-dependent kinase 2 (CDK2) activity. | ||||||
ACY-1215 | 1316214-52-4 | sc-507455 | 25 mg | $110.00 | ||
HDAC6 inhibitor, influencing ZMAT4 via epigenetic changes. | ||||||
ABT 737 | 852808-04-9 | sc-207242 | 2.5 mg | $204.00 | 54 | |
BCL-2 inhibitor, potentially impacting ZMAT4 pathways. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
mTOR inhibitor, affecting downstream signaling in ZMAT4. | ||||||
BX 795 | 702675-74-9 | sc-281689 sc-281689A sc-281689C sc-281689B sc-281689D sc-281689E | 2 mg 5 mg 10 mg 25 mg 50 mg 100 mg | $219.00 $273.00 $331.00 $495.00 $882.00 $1489.00 | 5 | |
Inhibits PDK1, influencing the PI3K/AKT pathway and ZMAT4. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β receptor inhibitor, affecting ZMAT4 via Smad pathway. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK-3β inhibitor, impacting Wnt signaling and ZMAT4. | ||||||
VX-11e | 896720-20-0 | sc-507301 | 10 mg | $180.00 | ||
Histone methyltransferase inhibitor, altering ZMAT4 gene expression. | ||||||